loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for r1_cep_2002_214___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NOVACYL Ecully FR

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

R1-CEP 2002-214 - Rev 04
Valid
Chemical
2021-04-29
49
Seqens Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Certificate Number : R1-CEP 2002-214 - Rev 04

Status : Valid

Issue Date : 2021-04-29

Type : Chemical

Substance Number : 49

Seqens Company Banner

Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-214 - Rev 04 of Novacyl Ecully Fr

Looking for Certificates of Suitability (CEPs) for R1-CEP 2002-214 - Rev 04 of Novacyl Ecully Fr 1

20

Novacyl Ecully Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

One of their significant offerings is Paracetamol, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-214 - Rev 04

This Chemical Type CEP, issued on April 29, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 49 associated with this CEP further emphasizes